Form 4 Tracker
Mark L. Jacobson

Chief Operating Officer · 5 filings · Latest: Sep 3, 2026

Axsome Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AXSM
Mark L. JacobsonChief Operating OfficerSep 3, 2026
Sale
$208.6510,000$2.1M0
AXSM
Mark L. JacobsonChief Operating OfficerSep 3, 2026
Option Exercise
$12.9510,000$129.5K10,000
AXSM
Mark Jacobson—Sep 3, 2026
Proposed Sale
$208.3510,000$2.1M—
AXSM
Mark L. JacobsonChief Operating OfficerMay 5, 2026
Sale
$228.18233$53.2K0
AXSM
Mark L. JacobsonChief Operating OfficerMay 5, 2026
Option Exercise
$12.95233$3.0K233
AXSM
Mark L. JacobsonChief Operating OfficerMay 4, 2026
Sale
$227.944,517$1.0M0
AXSM
Mark L. JacobsonChief Operating OfficerMay 4, 2026
Option Exercise
$12.954,517$58.5K4,517
AXSM
Mark Jacobson—May 5, 2026
Proposed Sale
$223.06233$52.0K—
AXSM
Mark Jacobson—May 4, 2026
Proposed Sale
$223.704,517$1.0M—
AXSM
Mark Jacobson—May 4, 2026
Proposed Sale
$223.704,517$1.0M—
AXSM
Mark L. JacobsonChief Operating OfficerFeb 26, 2026
Sale
$161.8835,378$5.7M0
AXSM
Mark L. JacobsonChief Operating OfficerFeb 26, 2026
Option Exercise
$2.8535,378$100.8K35,378
AXSM
Mark Jacobson—Feb 26, 2026
Proposed Sale
$163.1935,378$5.8M—
AXSM
Jacobson Mark L.—Sep 22, 2025
Proposed Sale
$115.9610,000$1.2M—
AXSM
Jacobson Mark L.—Sep 16, 2025
Proposed Sale
$114.4845,783$5.2M—
AXSM
Jacobson Mark L.—Jun 9, 2025
Proposed Sale
$110.4425,000$2.8M—
AXSM
Jacobson Mark L.—May 28, 2025
Proposed Sale
$103.4520,000$2.1M—
AXSM
Jacobson Mark L.—May 27, 2025
Proposed Sale
$0.0020,673$1—